Form 144: Proposed sale of 2,000 UTHR shares

United Therapeutics reported a Form 144 notice proposing the sale of 2,000 common shares.

Accepted by SEC EDGAR 03/04/2026 - 04:08 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

United Therapeutics reported a Form 144 notice proposing the sale of 2,000 common shares. The filing lists the proposed sale date as 03/04/2026, arising from a stock option exercise with proceeds to be received in cash. The record shows a prior sale of 910 shares on 12/18/2025 for $455,533.17.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does UTHR's Form 144 report?

It reports a proposed sale of 2,000 common shares on 03/04/2026. The filing states the sale arises from a stock option exercise and that proceeds will be received in cash.

Who is the reported selling party in the UTHR Form 144?

The filing lists Tommy Thompson at the provided address as the filer. Broker information names Morgan Stanley Smith Barney LLC, with execution details and the 03/04/2026 sale date shown.

How were the shares to be sold and when is the sale dated?

The 2,000 shares are tied to a stock option exercise and to be sold for cash. The proposed sale date in the filing is 03/04/2026.

Does the filing show recent prior sales by the same filer?

Yes — it discloses a prior sale of 910 common shares on 12/18/2025. That past sale is shown with a value of $455,533.17 in the excerpt.

What broker is listed for the proposed UTHR sale?

Morgan Stanley Smith Barney LLC is named in the securities and broker lines. The broker address and related execution details appear in the filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001324863
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UNITED THERAPEUTICS CORPORATION
SEC File Number	000-26301
Address of Issuer	1000 SPRING STREET SILVER SPRING MARYLAND 20910
Phone	(301) 608-9292
Name of Person for Whose Account the Securities are To Be Sold	TOMMY THOMPSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2000	978839.40	43827686	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2026	Stock Option Exercise	Issuer			2000	03/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TOMMY THOMPSON 1000 SPRING STREET SILVER SPRING MD 20910	Common	12/18/2025	910	455533.17

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Tommy George Thompson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)